Epidemiology of mature T/NK‐cell lymphomas in Germany – A representative cross‐sectional study based on SHI claims data
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2023
DOI: 10.1111/ddg.15187 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023. Verfasst von Chalid Assaf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, HELIOS Klinikum Krefeld, Krefeld, Germany. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Cutaneous, Skin Neoplasms, Mycosis Fungoides, Sezary Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Primary cutaneous lymphomas (PCL) are rare skin tumors of lymphoproliferative neoplasms and belong to the heterogeneous group of non‐Hodgkin's lymphomas. PCL encompass a broad spectrum of clinical and histologic manifestations, with cutaneous T‐cell lymphoma (CTCL) being the most common (73%). Due to the rarity of the diseases, population‐based studies of care and epidemiology are limited. Patients and methods Based on anonymized, age‐ and sex‐adjusted SHI (statutory health insurance) claims data of approximately five million SHI‐insured patients, a retrospective analysis was conducted over a six‐year period (2012–2017) to determine the prevalence, incidence, and lethality in patients with mature‐cell T/NK‐cell lymphoma in Germany.
Results
A total of 1,336 patients with T‐cell lymphoma were identified during the observation period. The six‐year prevalence ranged from 27.35 to 43.58 per 100,000. Patients were 65% male with a mean age of 66 years (SD 15). There were 246 patients (approx. 20%) who died within the 6 years, up to 7% per year. The calculated incidence in 153 identified patients in 2017 is 3.65 to 3.92 per 100,000.
Conclusions
For the first time, valid epidemiologic findings of patients with mature T‐cell and NK‐cell lymphomas were obtained using SHI claims data in Germany. Further analyses are needed to gain a deeper insight into the healthcare reality of patients with this rare disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Venerology, HELIOS Klinikum Krefeld, Krefeld, Germany.
- Institute for Molecular Medicine, Hamburg Medical School, Hamburg, Germany.
- Department of Dermatology, HELIOS Klinikum Schwerin, University Campus of the Hamburg Medical School, Schwerin, Germany.
- Clinic for Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, Joint Faculty of Medicine of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany.
- Kyowa Kirin GmbH, Düsseldorf, Germany.
Zitieren
APA
Assaf, C., Dobos, G., Zech, I. M., Doess, A., May, M., & Jadasz, J. (2023). Epidemiology of mature T/NK‐cell lymphomas in Germany – A representative cross‐sectional study based on SHI claims data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15187
Vancouver
Assaf C, Dobos G, Zech IM, Doess A, May M, Jadasz J. Epidemiology of mature T/NK‐cell lymphomas in Germany – A representative cross‐sectional study based on SHI claims data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023. doi:10.1111/ddg.15187
BibTeX
@article{Assaf2023,
author = {Assaf, Chalid and Dobos, Gabor and Zech, Immo-Maximilian and Doess, Axel and May, Melanie and Jadasz, Janusz},
title = {Epidemiology of mature T/NK‐cell lymphomas in Germany – A representative cross‐sectional study based on SHI claims data},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2023},
doi = {10.1111/ddg.15187}
}
EUVIMED